Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

[Q]: Not applicable. The story presented the outcome of 472 obese individuals and examined in more detail those who were able, on average, to loss 14 pounds over a period of 26 weeks. The story did not provide any insight as to whether this amount of weight loss resulted in any health improvement in the obese individuals who were studied. So the true benefit – the true significance of the potential benefit – was not explained. Further – while the study found that those who got an adequate amount of sleep were among the cohort of individuals who were found to lose the most weight, the story did not explicitly point out that the study does not inform us about whether enforced hours of sleep would impact weight loss and weight loss management. So, again, the headline, the story’s first sentence, and the call to action by the researcher were not balanced. The story was reporting on the impact of getting adequate amounts of sleep on weight loss. While there was no overt discussion of the harm of obtaining adequate amounts of sleep, there doesn’t appear to be any harm involved in adequate sleep. Similar to the LA Times story we reviewed on the same study, this story did not challenge researchers’ comments that went too far in promoting a call to action based on one observational study – a study that can’t prove cause and effect. Its opening sentence is an example of that flaw:  “If you’re looking to lose those extra pounds, you should probably add reducing stress and getting the right amount of sleep to the list…” Later, it didn’t challenge a researcher when he said, “If you want to lose weight, things that will help you include reducing stress and getting the right amount of sleep.”  That’s pushing the limits of what one can conclude based on one observational study and the story should have explained that limitation. Toward the end, in describing another study, it started in a good direction by explaining that conclusions “should be considered preliminary until published in a peer-reviewed journal.”  Actually, they should be considered preliminary because they were based on analysis of just 26 people. They should be considered to have evaded full scrutiny by expert colleagues until published in a peer-reviewed journal. Just because work has not been peer-reviewed does not make it preliminary. The intent, we think, was correct. But the explanation – the limitation – was not defined appropriately. The story did not engage in overt disease mongering. This story included expert quotes and also some insight from the results of a recently presented study. One of the strengths of this story in comparison with its shorter LA Times competition is the context it provided, much of it from an independent expert who said: “People who are healthy and vital tend to be healthy and vital not because of any one factor, but because of many. And the factors that promote health — eating well, being active, not smoking, sleeping enough, controlling stress, to name a few –promote all aspects of health. …The important message is that weight loss should not be looked at with tunnel vision. … This study encourages weight loss in a more holistic context.” Not applicable. The story was framed as taking a broader perspective when contemplating weight loss and including other lifestyle factors which can affect food intake and exercise. Better than its LA Times competition, at least this story nodded in the direction of one other recent study on sleep and weight, thereby conveying that the newer study is not the only research on this topic. It’s clear that the story did not rely solely on a news release.
[A]: Less Stress, Better Sleep May Help You Lose Weight


[Q]: Officials in Cumberland County say the Department of Health was told Saturday that a person affiliated with the university was hospitalized with a “possible diagnosis of a bacterial meningitis infection.” They did not say if the ill individual is a student. Officials say they are coordinating with the school and the state to provide antibiotics to anyone who had direct close contact with the individual. The university sent a campus-wide notification Saturday. Meningitis is an infection of the membranes surrounding the brain and spinal cord. The bacteria that cause the infection can spread through kissing, coughing and sharing beverages. Signs and symptoms of infection include high fever, headache, stiff neck and a rash.
[A]: Officials investigate possible meningitis case at NC college.


[Q]: The FDA’s Wednesday announcement of the visit, planned for February 10-18, comes less than two weeks after the FDA banned products from a fourth facility owned by Indian drugmaker Ranbaxy Laboratories Ltd due to manufacturing violations, effectively shutting the company out of the U.S. market for the foreseeable future. India is the second-largest exporter of drugs to the United States after Canada and the eighth-largest food exporter. Indian companies supply 40 percent of all drugs consumed in the United States, yet quality control problems have been rampant. Hamburg said the purpose of her visit is to “connect with my counterparts in the regulatory agencies as well as have a chance to talk with industry leaders who are important stakeholders in terms of our activities.”  She plans to visit Delhi, Mumbai and Cochin, where she will attend the World Spice Congress which runs from February 16-19. She will also visit a seafood processing facility and a spices facility. India accounted for 16 percent of U.S. spice imports by value in 2010 according to a recent FDA report, more than any other country. However, spice imports have been a source of food contamination. In October the FDA released figures showing that nearly 7 percent of all spice imports examined between 2007 and 2009 were contaminated with salmonella, while 12 percent of imported spices were contaminated with insects, hair and other filth. Mexico and India accounted for the highest percentage of contaminated shipments. Hamburg said she wants to build both professional relationships with her counterparts “and build the personal bonds as well.”  “We plan to sign a fairly broad memorandum of understanding to strengthen the ongoing working relationship,” she said. “It will be a fairly broad umbrella framework but will be important both practically and symbolically.”  She said she will not be visiting individual drug companies, but will have a round-table discussion with drug company chief executives. Part of the discussion will focus on quality control. “We have made it very clear that we have a set of quality standards that we will adhere to,” Hamburg said, adding that the message will be reiterated. “It needs to be a very clear message, but it is a message they will not be surprised by.”  In December Jubilant Life Sciences Ltd received a warning letter from the FDA over manufacturing practices at one of its U.S. facilities. In November the FDA effectively banned products from a second plant operated by Wockhardt Ltd.  “We have a responsibility to ensure quality, whether of drugs manufactured in this country or outside our borders,” Hamburg said.
[A]:
As quality control violations rise, FDA chief heads to India.